Key result
TENS causes minor electromagnetic interference in ~16% of patients with ICDs or CRT-Ds.
Why the study?
Transcutaneous electrical nerve stimulation (TENS) is considered contraindicated in ICD patients due to electromagnetic interference, but supporting data may be outdated given advances in ICD and CRT filtering and noise protection algorithms.
What is the risk of electromagnetic interference on the sensing function of modern implantable cardioverter-defibrillators during the application of transcutaneous electrical nerve stimulation?
Observational (n=107)
Both physicians and patients were not blinded
standardized but nonrandomized order of testing
No
What is the risk of electromagnetic interference on the sensing function of modern implantable cardioverter-defibrillators during the application of transcutaneous electrical nerve stimulation?
Answers are grounded in this paper and cite their sources.
Although EMI rates with modern ICDs during TENS are lower than in historical reports (15.9% overall, 2.8% at the cervical spine) and events were intermittent and minor, supervised device testing by a cardiac specialist remains necessary before prescribing TENS to ICD patients.
BACKGROUND: Transcutaneous electrical nerve stimulation (TENS) is an established method for pain relief. But electrical TENS currents are also a source of electromagnetic interference (EMI). Thus, TENS is considered to be contraindicated in implantable cardioverter-defibrillator (ICD) patients. However, data might be outdated due to considerable advances in ICD and cardiac resynchronization therapy (CRT) filtering and noise protection algorithm technologies. The aim of this pilot safety study was to re-evaluate the safety of TENS in patients with modern ICDs. METHODS AND RESULTS: One hundred and seven patients equipped with 55 different models of ICD/CRT with defibrillators from 4 manufacturers underwent a standardized test protocol including TENS at the cervical spine and the thorax, at 2 stimulation modes-high-frequency TENS (80 Hz) and burst-mode TENS (2 Hz). Potential interference monitoring included continuous documentation of ECG Lead II, intracardiac electrograms and the marker channel. Electromagnetic interference was detected in 17 of 107 patients (15.9%). Most frequent were: interpretations as a premature ventricular beats (VS/S) in 15 patients (14%), noise reversion in 5 (4.6%) which resulted in temporary asynchronous pacing in 3 (2.8%), interpretation as ventricular tachycardia/ventricular fibrillation in 2 (1.9%), and premature atrial beat in 2 (1.9%) patients. Electromagnetic interference occurrence was influenced by position (chest, P < 0.01), higher current intensity (P < 0.01), and manufacturer (P = 0.012). CONCLUSION: Overall, only intermittent and minor EMI were detected. Prior to the use of TENS in patients with ICDs, they should undergo testing under the supervision of a cardiac device specialist.
No takes yet. Share an insight, caveat, or question.
Arain et al. (2023) conducted an observational in Patients with implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy with defibrillator (CRT-D) systems (n=107). Transcutaneous electrical nerve stimulation (TENS) vs. Baseline recording with patches placed at cervical spine and chest without current flow was evaluated on Occurrence of electromagnetic interference (EMI). Transcutaneous electrical nerve stimulation (TENS) caused intermittent, minor electromagnetic interference in 15.9% (17/107) of patients with modern ICD or CRT-D systems.
Synapse has enriched 10 related papers. Consider them for comparative context: